BackOrchestra BioMed Holdings Overview

Orchestra BioMed Holdings Accounts Payable

Track Orchestra BioMed Holdings's accounts payable ($6.3M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$6.31M
13.48% YoYΔ $750000.00 vs prior year quarter

Peer average

Loading

Orchestra BioMed Holdings Accounts Payable History

Loading

Orchestra BioMed Holdings vs. peers: Accounts Payable Comparison

Loading

Orchestra BioMed Holdings Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Orchestra BioMed Holdings (OBIO) FAQ

As of the most recent data (March 2026), OBIO shows a accounts payable of $6.3M. That compares with $5.6M in the prior-year period — up 13.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, OBIO's accounts payable is now $6.3M (was $5.6M) — a 13.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Orchestra BioMed Holdings is outperforming or lagging.

Tracking OBIO's accounts payable over time shows whether Orchestra BioMed Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $6.3M That compares with $5.6M in the prior-year period — up 13.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Orchestra BioMed Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $6.3M) with ownership activity and broader fundamentals.